{"schema":"hottub-news/prospects/v1","item":{"id":"n_sliomqmvj7ezqhpedgea","title":"Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis","title_en":null,"url":"https://www.finanzen.ch/nachrichten/aktien/regeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355","outlet":"finanzen.ch","published":"2026-11-19T04:55:00Z","sponsored":false,"page":"https://hottub.news/articles/n_sliomqmvj7ezqhpedgea"},"prospects":[{"name":"United States Food and Drug Administration","kind":"organization","role":"named","entity":"wikidata:Q204711","source":"https://www.finanzen.ch/nachrichten/aktien/regeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355","note":"In the news: Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis (finanzen.ch, 2026-11-19)","reason":"Named in a headline on 2026-11-19: “Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis” (finanzen.ch)","group":"Organizations","add_url":"https://crm.joinhottub.com/relationships/add#name=United%20States%20Food%20and%20Drug%20Administration&kind=organization&source=https%3A%2F%2Fwww.finanzen.ch%2Fnachrichten%2Faktien%2Fregeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355&entity=wikidata%3AQ204711&note=In%20the%20news%3A%20Regeneron%20Wins%20FDA%20Approval%20For%20Livsayis%20In%20Generalized%20Myasthenia%20Gravis%20%28finanzen.ch%2C%202026-11-19%29","propose":{"name":"United States Food and Drug Administration","kind":"organization","reason":"Named in a headline on 2026-11-19: “Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis” (finanzen.ch)","requestId":"news:n_sliomqmvj7ezqhpedgea:wikidata:Q204711:0ecdda22","sourceUrl":"https://www.finanzen.ch/nachrichten/aktien/regeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355","entity":"wikidata:Q204711"}},{"name":"finanzen.ch","kind":"organization","role":"outlet","website":"https://finanzen.ch/","source":"https://www.finanzen.ch/nachrichten/aktien/regeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355","note":"Published: Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis (2026-11-19)","reason":"Published “Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis” on 2026-11-19","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=finanzen.ch&kind=organization&website=https%3A%2F%2Ffinanzen.ch%2F&source=https%3A%2F%2Fwww.finanzen.ch%2Fnachrichten%2Faktien%2Fregeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355&note=Published%3A%20Regeneron%20Wins%20FDA%20Approval%20For%20Livsayis%20In%20Generalized%20Myasthenia%20Gravis%20%282026-11-19%29","propose":{"name":"finanzen.ch","kind":"organization","reason":"Published “Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis” on 2026-11-19","requestId":"news:n_sliomqmvj7ezqhpedgea:Outlet:d52e0b0f:f3982d76","website":"https://finanzen.ch/","sourceUrl":"https://www.finanzen.ch/nachrichten/aktien/regeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355"}}],"someone_else":{"source":"https://www.finanzen.ch/nachrichten/aktien/regeneron-wins-fda-approval-for-livsayis-in-generalized-myasthenia-gravis-1036781355","note":"In the news: Regeneron Wins FDA Approval For Livsayis In Generalized Myasthenia Gravis (finanzen.ch, 2026-11-19)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}